CAGGIA, Federica
 Distribuzione geografica
Continente #
NA - Nord America 4.403
EU - Europa 2.430
AS - Asia 2.219
SA - Sud America 343
AF - Africa 63
Continente sconosciuto - Info sul continente non disponibili 59
OC - Oceania 5
Totale 9.522
Nazione #
US - Stati Uniti d'America 4.278
SG - Singapore 682
CN - Cina 572
DE - Germania 534
IT - Italia 531
GB - Regno Unito 509
BR - Brasile 252
VN - Vietnam 247
HK - Hong Kong 228
SE - Svezia 163
BD - Bangladesh 154
IE - Irlanda 137
FI - Finlandia 132
RU - Federazione Russa 129
FR - Francia 75
UA - Ucraina 72
IN - India 65
CA - Canada 62
KR - Corea 59
ID - Indonesia 40
TR - Turchia 40
AR - Argentina 34
MX - Messico 34
NL - Olanda 31
BG - Bulgaria 25
JP - Giappone 17
PL - Polonia 17
CO - Colombia 16
IQ - Iraq 14
ZA - Sudafrica 14
MA - Marocco 13
CL - Cile 12
LT - Lituania 12
EC - Ecuador 11
ES - Italia 11
SA - Arabia Saudita 11
KE - Kenya 10
AE - Emirati Arabi Uniti 9
VE - Venezuela 9
AT - Austria 8
EG - Egitto 8
CH - Svizzera 7
CZ - Repubblica Ceca 7
PH - Filippine 7
PK - Pakistan 7
TH - Thailandia 7
MY - Malesia 6
SY - Repubblica araba siriana 6
TW - Taiwan 6
CR - Costa Rica 5
HN - Honduras 5
IR - Iran 5
JM - Giamaica 5
JO - Giordania 5
LB - Libano 4
NP - Nepal 4
RS - Serbia 4
SI - Slovenia 4
AU - Australia 3
BE - Belgio 3
BH - Bahrain 3
DO - Repubblica Dominicana 3
GR - Grecia 3
IL - Israele 3
MK - Macedonia 3
NG - Nigeria 3
PE - Perù 3
SV - El Salvador 3
TN - Tunisia 3
UZ - Uzbekistan 3
AL - Albania 2
AZ - Azerbaigian 2
BO - Bolivia 2
CI - Costa d'Avorio 2
EU - Europa 2
GE - Georgia 2
HU - Ungheria 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LK - Sri Lanka 2
NZ - Nuova Zelanda 2
OM - Oman 2
PT - Portogallo 2
PY - Paraguay 2
RO - Romania 2
SN - Senegal 2
UY - Uruguay 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BI - Burundi 1
BS - Bahamas 1
BW - Botswana 1
CW - ???statistics.table.value.countryCode.CW??? 1
DK - Danimarca 1
DM - Dominica 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
Totale 9.454
Città #
Ashburn 610
Singapore 432
Santa Clara 344
Southend 297
San Jose 281
Hong Kong 222
Chandler 215
Hefei 178
Fairfield 174
Woodbridge 164
Dublin 137
Munich 130
Houston 128
Council Bluffs 123
Beijing 118
Dallas 114
Jacksonville 113
Los Angeles 112
Nyköping 107
Dearborn 101
New York 97
Helsinki 96
Chicago 88
Wilmington 86
Ho Chi Minh City 85
Seattle 74
London 70
Cambridge 67
Seoul 59
Modena 55
Hanoi 50
Milan 46
The Dalles 41
Salt Lake City 38
Lauterbourg 33
Bologna 32
Enfield 32
Fremont 32
Rome 32
Ann Arbor 31
Buffalo 28
Jakarta 27
São Paulo 27
Shanghai 26
Columbus 23
Orem 23
Princeton 23
Sofia 22
Phoenix 21
San Diego 21
Tampa 20
Toronto 20
Eugene 19
Moscow 18
Bremen 15
Turku 15
Atlanta 14
Frankfurt am Main 14
Reggio Emilia 14
Chennai 13
Elk Grove Village 13
Falls Church 13
Izmir 13
Boardman 11
Brooklyn 11
Da Nang 11
Denver 11
Des Moines 11
Guangzhou 11
Lancaster 11
Mexico City 11
Parma 11
Stockholm 11
Tokyo 11
Istanbul 10
Manchester 10
Miami 10
Nairobi 10
Nanjing 10
Redondo Beach 10
San Francisco 10
Dong Ket 9
Johannesburg 9
Kent 9
Newark 9
Poplar 9
Redwood City 9
Warsaw 9
Dhaka 8
Haiphong 8
Naples 8
Baghdad 7
Brasília 7
Charlotte 7
Montreal 7
Nuremberg 7
Ottawa 7
Querétaro 7
Sterling 7
Amsterdam 6
Totale 6.026
Nome #
Early neonatal inflammation affects adult pain reactivity and anxiety related traits in mice: genetic background counts 592
Time-dependent effects of escitalopram on brain derived neurotrophic factor (BDNF) and neuroplasticity related targets in the central nervous system of rats 510
Stress induces altered CRE/CREB pathway activity and BDNF expression in the hippocampus of glucocorticoid receptor-impaired mice 417
Constitutive and LPS-regulated expression of interleukin-18 receptor beta variants in the mouse brain 414
Clinical and molecular analysis of long-term HER2 positive metastatic breast cancer survivors. 392
Microarray analysis of the chronic escape deficit model of depression: Effects of escitalopram treatment in hippocampus 384
Central effects of a local inflammation in three commonly used mouse strains with a different anxious phenotype 383
Quality of life and anxious-depressive symptoms in cancer patients undergoing mindfulness-based interventions: Feasibility and preliminary outcomes on prospective single-centre case-control study (MIND4ME St.) 363
Impaired stress-induced regulation of brain derived neurotrophic factor expression in hippocampus of glucocorticoid receptor impaired mice: Model of depression 362
Clinical and molecular predictors of long-term response in HER2 positive metastatic breast cancer patients. 337
Molecular effects of subchronic andchronic treatment with escitalopram inthe rat central nervous system 334
Clinical-Pathological Characteristics of HER2+ Breast Cancers patients among BRCA1/2+ carriers tested in Modena Cancer Center. 327
Molecular profile in primary and metastatic breast cancer treated with Exemestane and Everolimus. 323
Impact of time to surgery after neoadjuvant chemotherapy in patients with operable breast cancer. 322
Differential gene expression patterns in HER2 positive metastatic breast cancer patients according to hormone receptor status 321
Microarray analysis in hippocampus of rats treated with escitalopram in the chronic escape deficit model of depression 317
Clinicopathologic Profile of Breast Cancer in Germline ATM and CHEK2 Mutation Carriers 317
Predictive factors for relapse in triple-negative breast cancer patients without pathological complete response after neoadjuvant chemotherapy 312
Gene expression profile of the hippocampus of a behavioural model of depression 306
Impact of anaemia on tumor response to neoadjuvant chemotherapy in breast cancer patients . 288
Adjuvant exemestane or tamoxifen plus ovarian suppression in premenopausal women: single institution analysis 277
Differential gene expression patterns in HER2 positive metastatic breast cancer patients according to hormone receptor status. 277
Targeting PI3K/AKT/mTOR Pathway in Breast Cancer: From Biology to Clinical Challenges 272
T-DM1 efficacy in trastuzumab-pertuzumab pre-treated HER2 positive metastatic breast cancer patients: a meta-analysis 258
Next Generation Sequencing (NGS): a possible game changer in metastatic breast cancer 235
Extracellular vesicles-derived miR-21 as a biomarker for early diagnosis and tumor activity in breast cancer subtypes 181
Safety and efficacy analysis of neoadjuvant pertuzumab, trastuzumab and standard chemotherapy for HER2–positive early breast cancer: real–world data from NeoPowER study 178
A phase II study of pembrolizumab plus carboplatin in BRCA-related metastatic breast cancer (PEMBRACA) 176
TDM-1 efficacy in trastuzumabpertuzumab pre-treated HER2 positive metastatic breast cancer patients: a meta-analysis 172
Time to next treatment to evaluate the therapeutic sequence after first- or second-line CDK4/6 inhibitors of hormone receptor-positive, HER2-negative advanced breast cancer in Italy: a retrospective/prospective observational trial GOIRC-04-2019 77
Real-world effectiveness of PARP inhibitors after CDK4/6 inhibitor therapy in BRCA-mutated HR-positive/HER2-negative advanced breast cancer 53
Update on Pulmonary Toxicity Induced by New Breast Cancer Treatments. 45
Totale 9.522
Categoria #
all - tutte 33.918
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.918


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022308 0 0 0 25 18 29 15 10 38 43 75 55
2022/2023759 66 92 46 71 48 69 12 57 170 9 85 34
2023/2024489 19 23 33 70 72 49 55 50 11 17 33 57
2024/20251.643 39 22 40 101 265 226 181 118 184 104 143 220
2025/20263.602 256 139 298 408 641 223 384 160 300 336 243 214
2026/2027663 106 160 241 156 0 0 0 0 0 0 0 0
Totale 9.522